China Dasheng Biotechnology (CDBT) 10-Q 2009 Q3 Quarterly report

EXHIBIT 32

Rule 13a-14(b) Certification

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of China Dasheng Biotechnology Company. (the "Company") certify that:

1.

The Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2009 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 12, 2009

By: /s/ Sidong Zhang                                              
       Sidong Zhang, Chief Executive Officer

By: /s/ Hongsheng Wang                                       
       Hongsheng Wang, Chief Financial Officer